For the eighth year, the Aesthetic Surgery Center is honored by the Naples Community's Choice Awards, with recognition spanning surgical...
Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia...
CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology...
CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company...
STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its participation at ASTRO in San...
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to...
AUSTIN, Texas and TOKYO, Sept. 25, 2025 /PRNewswire/ -- The Digital Pathology Market Size reached US$ 1.31 Billion in 2024...
Internationally recognized expert joins to support the organization's commercialization strategy MADISON, Wis., Sept. 25, 2025 /PRNewswire/ -- Elephas Biosciences Corporation...
Building a Future Experience for Children Facing Treatment with Play and Positivity MIDDLETON, Wis., Sept. 25, 2025 /PRNewswire/ -- Every...
Miltenyi Bioindustry division to supply commercial-ready lentiviral vector to support STAR-101 clinical trial PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Verismo Therapeutics,...
Thyme Care achieves profitability, manages more than $5B in oncology spend, and extends access to 8M people nationwide in a...
Integrated Solution with Koios Software Helps Clinicians Improve Detection While Enhancing Workflow Efficiencies TORONTO and NEW YORK, Sept. 25, 2025...
Funding will fuel rapid expansion of the Columbus-based oncology platform, which connects community oncologists with subspecialty experts and real-world insights...
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment...
Company Successfully Meets Both Minimum Bid Price and Shareholders' Equity Requirements, Securing Continued Listing on the Nasdaq Capital MarketGRAND CAYMAN,...
Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is...
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative...
First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of...
Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records.Potential future T...